Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
ES17 - Cost and Accessibility to Lung Cancer Drugs - Pathways to Improvement
- 11:00 - 12:00
- 8/08/2022
- Location:
- IASLC CME Accredited
- Type: Education Session
- Track: Global Health, Health Services Research, and Health Economics
-
+
ES18 - Management of Pulmonary Nodules
- 11:00 - 12:00
- 8/08/2022
- Location: Strauss 1/2
- IASLC CME Accredited
- Type: Education Session
- Track: Pulmonology, Radiology, and Staging
- Moderators:Edith Michelle Marom, wentao fang
-
+
Session Moderator
11:14 - 11:26 | Presenter: Edith Michelle Marom
- Abstract
Loading... -
+
Session Moderator
11:14 - 11:26 | Presenter: wentao fang
- Abstract
Loading... -
+
ES18.01 - Session Introduction
11:00 - 11:01 | Presenter: Edith Michelle Marom
- Abstract
Loading... -
+
ES18.02 - Session Introduction
11:01 - 11:02 | Presenter: wentao fang
- Abstract
Loading... -
+
ES18.03 - Preneoplasia Management Strategies
11:02 - 11:14 | Presenter: Seung Hun Jang
- Abstract
Loading... -
+
ES18.04 - Nodule Measurements: Diameter vs. Volume
11:14 - 11:26 | Presenter: Ritu Gill
- Abstract
Loading... -
+
ES18.05 - Biopsy and Localization of Nodules
11:26 - 11:38 | Presenter: Yeun-Chung Chang
- Abstract
Loading... -
+
ES18.06 - Managing Indeterminate Pulmonary Nodules: Current Best Practice
11:38 - 11:50 | Presenter: Hans-Ulrich Kauczor
- Abstract
Loading... -
+
ES18.07 - Live Q&A
11:50 - 12:00
- Abstract
Loading...
-
+
OA06 - Impact of COVID-19 on Cancer Management and Protection from Vaccines
- 11:00 - 12:10
- 8/08/2022
- Location: Lehar 1
- Not for CME Credit
- Type: Oral
- Track: Management of Lung Cancer in the Era of COVID-19
- Moderators:Marina Chiara Garassino, Christian Grohe
-
+
Session Moderator
11:42 - 11:52 | Presenter: Marina Chiara Garassino
- Abstract
Loading... -
+
Session Moderator
11:42 - 11:52 | Presenter: Christian Grohe
- Abstract
Loading... -
+
OA06.01 - Session Introduction
11:00 - 11:01 | Presenter: Marina Chiara Garassino
- Abstract
Loading... -
+
OA06.02 - Session Introduction
11:01 - 11:02 | Presenter: Christian Grohe
- Abstract
Loading... -
+
OA06.03 - Serological Response to SARS-CoV-2 Vaccination in Patients Lung Cancer: A Mount Sinai-Led Prospective Matched Controlled Study
11:02 - 11:12 | Presenter: Philip C Mack
- Abstract
Loading... -
+
OA06.04 - Immune Response after SARS-CoV-2 Vaccination in Lung Cancer Patients. Update of the Covid Lung Vaccine Cohort
11:12 - 11:22 | Presenter: Ainhoa Hernandez
- Abstract
Loading... -
+
OA06.05 - Impact of COVID-19 Pandemic on Proportion and Treatment Patterns for Stage I Non-small Cell Lung Cancer in the Netherlands
11:22 - 11:32 | Presenter: Nienke Wolfhagen
- Abstract
Loading... -
+
OA06.06 - Impact of Systemic Anti-cancer Treatments on Outcomes of COVID-19 in Patients with Thoracic Cancers: CCC19 Registry Analysis
11:32 - 11:42 | Presenter: Amit Kulkarni
- Abstract
Loading... -
+
OA06.07 - Stereotactic Ablative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts
11:42 - 11:52 | Presenter: Biniam Kidane
- Abstract
Loading... -
+
OA06.08 - Discussant
11:52 - 12:02 | Presenter: Marina Chiara Garassino
- Abstract
Loading... -
+
OA06.09 - Live Q&A
12:02 - 12:10
- Abstract
Loading...
-
+
OA07 - Is There Still a Role for Chemotherapy Alone in the Management of NSCLC?
- 11:00 - 12:00
- 8/08/2022
- Location: Hall C7
- Not for CME Credit
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy
- Moderators:Lubos Petruzelka, Pilar Garrido
-
+
Session Moderator
11:22 - 11:32 | Presenter: Lubos Petruzelka
- Abstract
Loading... -
+
Session Moderator
11:22 - 11:32 | Presenter: Pilar Garrido
- Abstract
Loading... -
+
OA07.01 - Session Introduction
11:00 - 11:01 | Presenter: Lubos Petruzelka
- Abstract
Loading... -
+
OA07.02 - Session Introduction
11:01 - 11:02 | Presenter: Pilar Garrido
- Abstract
Loading... -
+
OA07.03 - Association Between Genetic Variation in the ATP-binding Cassette Transporter ABCC10 and nab-PTX Treatment in Japanese Cohort
11:02 - 11:12 | Presenter: Minoru Horiuchi
- Abstract
Loading... -
+
OA07.04 - Overall Survival in Patients With Advanced NSCLC Receiving Taxane-Containing Regimen After Exposure to Immunotherapy and Platinum-Doublet
11:12 - 11:22 | Presenter: Stephen V. Liu
- Abstract
Loading... -
+
OA07.05 - Gemcitabine Plus Platinum Chemotherapy Re-challenge in Metastatic Pulmonary Lymphoepithelioma-like Carcinoma
11:22 - 11:32 | Presenter: Gavin Tin Chun Cheung
- Abstract
Loading... -
+
OA07.06 - Second Line Treatment Outcomes After Progression on Immunotherapy Plus Chemotherapy (IO-CT) In Advanced Non-small Cell Lung Cancer (aNSCLC)
11:32 - 11:42 | Presenter: Edouard Auclin
- Abstract
Loading... -
+
OA07.07 - Discussant
11:42 - 11:52 | Presenter: Navneet Singh
- Abstract
Loading... -
+
OA07.08 - Live Q&A
11:52 - 12:00
- Abstract
Loading...
-
+
OA08 - Multidisciplinary Care of the Lung Cancer Patient
- 11:00 - 12:00
- 8/08/2022
- Location: Strauss 3
- Not for CME Credit
- Type: Oral
- Track: Nursing and Allied Health Professionals
- Moderators:Shankar Siva, Sun Min Lim
-
+
Session Moderator
11:00 - 11:00 | Presenter: Sun Min Lim
- Abstract
Loading... -
+
Session Moderator
11:00 - 11:00 | Presenter: Shankar Siva
- Abstract
Loading... -
+
OA08.01 - Session Introduction
11:00 - 11:01 | Presenter: Shankar Siva
- Abstract
Loading... -
+
OA08.02 - Session Introduction
11:01 - 11:02 | Presenter: Sun Min Lim
- Abstract
Loading... -
+
OA08.03 - Do in Screening - Calf Circumference and Muscle Strength is Predictive of Outcomes in Lung Cancer Treatment.
11:02 - 11:12 | Presenter: Imanuely Borchardt
- Abstract
Loading... -
+
OA08.04 - The Impact of Video-fluoroscopic Swallow Assessment on Dysphagia Management in Lung Cancer
11:12 - 11:22 | Presenter: Ashton Brower
- Abstract
Loading... -
+
OA08.05 - A Quality Improvement Project Determining if Dietitian Input with the UHS Lung Oncology Team Improved Patient Outcomes.
11:22 - 11:32 | Presenter: Ann-Marie Jones
- Abstract
Loading... -
+
OA08.06 - Implementation of a Nurse-led Geriatric Oncology Assessment Model in the Lung Cancer Care Pathway
11:32 - 11:42 | Presenter: Polly H Dufton
- Abstract
Loading... -
+
OA08.07 - Discussant
11:42 - 11:52 | Presenter: Jacqui Frowen
- Abstract
Loading... -
+
OA08.08 - Live Q&A
11:52 - 12:00
- Abstract
Loading...
-
+
ES19 - Toxicity Avoidance in SABR for Early Stage NSCLC
- 12:15 - 13:15
- 8/08/2022
- Location: Hall C1
- IASLC CME Accredited
- Type: Education Session
- Track: Early Stage Non-small Cell Lung Cancer - Radiotherapy and Other Ablative Techniques
- Moderators:Lizza Hendriks, Shankar Siva
-
+
Session Moderator
12:15 - 12:15 | Presenter: Lizza Hendriks
- Abstract
Loading... -
+
Session Moderator
12:15 - 12:15 | Presenter: Shankar Siva
- Abstract
Loading... -
+
ES19.01 - Session Introduction
12:15 - 12:16 | Presenter: Lizza Hendriks
- Abstract
Loading... -
+
ES19.02 - Session Introduction
12:16 - 12:17 | Presenter: Shankar Siva
- Abstract
Loading... -
+
ES19.03 - SABR in the Ultracentral Lesions
12:17 - 12:29 | Presenter: Kevin Franks
- Abstract
Loading... -
+
ES19.04 - Heart Matters in Lung SABR
12:29 - 12:41 | Presenter: Pamela Samson
- Abstract
Loading... -
+
ES19.05 - SABR in Patients with Interstitial Lung Disease
12:41 - 12:53 | Presenter: Yeon Sil Kim
- Abstract
Loading... -
+
ES19.06 - Chest Wall Myositis, Pleuritis and Rib Fracture
12:53 - 13:05 | Presenter: Maria Werner-Wasik
- Abstract
Loading... -
+
ES19.07 - Live Q&A
13:05 - 13:15
- Abstract
Loading...
-
+
ES20 - Management of Lung Cancer in the Era of COVID-19 II
- 12:15 - 13:15
- 8/08/2022
- Location: Hall C2
- IASLC CME Accredited
- Type: Education Session
- Track: Management of Lung Cancer in the Era of COVID-19
- Moderators:Andrea Bezjak, Milena Cavic
-
+
Session Moderator
12:16 - 12:17 | Presenter: Andrea Bezjak
- Abstract
Loading... -
+
Session Moderator
12:16 - 12:17 | Presenter: Milena Cavic
- Abstract
Loading... -
+
ES20.01 - Session Introduction
12:15 - 12:16 | Presenter: Andrea Bezjak
- Abstract
Loading... -
+
ES20.02 - Session Introduction
12:16 - 12:17 | Presenter: Milena Cavic
- Abstract
Loading... -
+
ES20.03 - COVID-19 and Its Complications in Patients With Lung Cancer
12:17 - 12:29 | Presenter: Kwun Meng Fong
- Abstract
Loading... -
+
ES20.04 - Impact of COVID-19 on Lung Cancer and Mesothelioma Specialist Nurses
12:29 - 12:41 | Presenter: Sarah Hargreaves
- Abstract
Loading... -
+
ES20.05 - Intensive Care for Lung Cancer Patients
12:41 - 12:53 | Presenter: Erwin Grasmuk-Siegl
- Abstract
Loading... -
+
ES20.06 - Telemedicine in 2021: Pros and Cons
12:53 - 13:05 | Presenter: Howard (Jack) West
- Abstract
Loading... -
+
ES20.07 - Live Q&A
13:05 - 13:15
- Abstract
Loading...
-
+
ES21 - Problems and Controversies in Lung Tumours
- 12:15 - 13:15
- 8/08/2022
- Location: Strauss 1/2
- IASLC CME Accredited
- Type: Education Session
- Track: Pathology
- Moderators:Jin-Haeng Chung, Sylvie Lantuejoul
-
+
Session Moderator
12:29 - 12:41 | Presenter: Jin-Haeng Chung
- Abstract
Loading... -
+
Session Moderator
12:29 - 12:41 | Presenter: Sylvie Lantuejoul
- Abstract
Loading... -
+
ES21.01 - Session Introduction
12:15 - 12:16 | Presenter: Jin-Haeng Chung
- Abstract
Loading... -
+
ES21.02 - Session Introduction
12:16 - 12:17 | Presenter: Sylvie Lantuejoul
- Abstract
Loading... -
+
ES21.03 - G3NET/Supracarcinoids
12:17 - 12:29 | Presenter: Mauro Papotti
- Abstract
Loading... -
+
ES21.04 - SCLC Subtypes
12:29 - 12:41 | Presenter: Natasha Rekhtman
- Abstract
Loading... -
+
ES21.05 - LCNEC: Where Are We with Diagnosis?
12:41 - 12:53 | Presenter: Teodora Radonic
- Abstract
Loading... -
+
ES21.06 - Molecular Profiling and Biomarkers in Lung NET. Any Closer?
12:53 - 13:05 | Presenter: Alexandra Sexton-Oates
- Abstract
Loading... -
+
ES21.07 - Live Q&A
13:05 - 13:15
- Abstract
Loading...
-
+
MA06 - Resectable and Unresectable Locally Advanced Lung Cancer
- 12:15 - 13:15
- 8/08/2022
- Location: Lehar 1
- Not for CME Credit
- Type: Mini Oral
- Track: Locally Advanced Non-small Cell Lung Cancer
- Moderators:Saulius Cicenas, Celine Mascaux
-
+
Session Moderator
12:16 - 12:17 | Presenter: Saulius Cicenas
- Abstract
Loading... -
+
Session Moderator
12:16 - 12:17 | Presenter: Celine Mascaux
- Abstract
Loading... -
+
MA06.01 - Session Introduction
12:15 - 12:16 | Presenter: Saulius Cicenas
- Abstract
Loading... -
+
MA06.02 - Session Introduction
12:16 - 12:17 | Presenter: Celine Mascaux
- Abstract
Loading... -
+
MA06.03 - Pre-treatment ctDNA Levels Significantly Predicts of OS and PFS in NADIM II Trial
12:17 - 12:22 | Presenter: Atocha Romero
- Abstract
Loading... -
+
MA06.04 - Phase II Study of Durvalumab Plus Concurrent Radiotherapy in Unresectable Locally Advanced NSCLC: DOLPHIN Study (WJOG11619L)
12:22 - 12:27 | Presenter: Motoko Tachihara
- Abstract
Loading... -
+
MA06.05 - Consolidation Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation for Patients with Unresectable Stage III NSCLC
12:27 - 12:32 | Presenter: Greg Andrew Durm
- Abstract
Loading... -
+
MA06.06 - Discussant
12:32 - 12:42 | Presenter: Andrea Bille
- Abstract
Loading... -
+
MA06.07 - Molecular Typing of pN2 Lung Adenocarcinoma: A Retrospective Study Based on Transcriptome Sequencing
12:42 - 12:47 | Presenter: Jianfei Zhu
- Abstract
Loading... -
+
MA06.08 - Long-term Survival and Competing Risks of Death in the ESPATUE Randomized Phase-III Trial in Stage III NSCLC
12:47 - 12:52 | Presenter: Wilfried Ernst Erich Eberhardt
- Abstract
Loading... -
+
MA06.09 - Deep Learning for Predicting MPR to Neoadjuvant Immunotherapy in NSCLC
12:52 - 12:57 | Presenter: Yifan Zhong
- Abstract
Loading... -
+
MA06.10 - Discussant
12:57 - 13:07 | Presenter: Dawn Owen
- Abstract
Loading... -
+
MA06.11 - Live Q&A
13:07 - 13:15
- Abstract
Loading...
-
+
MA07 - Overcoming Resistance to EGFR Inhibitors
- 12:15 - 13:15
- 8/08/2022
- Location: Hall C7
- Not for CME Credit
- Type: Mini Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Moderators:Dana Lucia Stanculeanu, Ross Soo
-
+
Session Moderator
13:07 - 13:15 | Presenter: Dana Lucia Stanculeanu
- Abstract
Loading... -
+
Session Moderator
13:07 - 13:15 | Presenter: Ross Soo
- Abstract
Loading... -
+
MA07.01 - Session Introduction
12:15 - 12:16 | Presenter: Dana Lucia Stanculeanu
- Abstract
Loading... -
+
MA07.02 - Session Introduction
12:16 - 12:17 | Presenter: Ross Soo
- Abstract
Loading... -
+
MA07.03 - Real-world Landscape of EGFR C797X Mutation as a Resistance Mechanism to Osimertinib in Non-small Cell Lung Cancer
12:17 - 12:22 | Presenter: Suresh S. Ramalingam
- Abstract
Loading... -
+
MA07.04 - Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy in Relapsed/Refractory EGFR-mutant NSCLC
12:22 - 12:27 | Presenter: Melina Elpi Marmarelis
- Abstract
Loading... -
+
MA07.05 - Phase 1b/2 Study of Combined HER Inhibition in Refractory EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)
12:27 - 12:32 | Presenter: Jonathan Goldman
- Abstract
Loading... -
+
MA07.06 - Discussant
12:32 - 12:42 | Presenter: Laura Mezquita
- Abstract
Loading... -
+
MA07.07 - Clinical/Molecular Profile of Patients with Non-small Cell Lung Cancer (NSCLC) with Incidental Pathogenic Germline Variants Detected in cfDNA
12:42 - 12:47 | Presenter: Laura Mezquita
- Abstract
Loading... -
+
MA07.08 - JIN-A02, a Highly Effective 4th Generation EGFR-TKI, Targeting EGFR C797S Triple Mutation in NSCLC
12:47 - 12:52 | Presenter: Byoung Chul Cho
- Abstract
Loading... -
+
MA07.09 - BBT-176, a 4th generation EGFR TKI, for Progressed NSCLC after EGFR TKI Therapy: PK, Safety and Efficacy from Phase 1 Study
12:52 - 12:57 | Presenter: Sun Min Lim
- Abstract
Loading... -
+
MA07.10 - Discussant
12:57 - 13:07 | Presenter: Pasi A Janne
- Abstract
Loading... -
+
MA07.11 - Live Q&A
13:07 - 13:15
- Abstract
Loading...
first
prev
